Free Trial

Genus (LON:GNS) Reaches New 12-Month High - What's Next?

Genus logo with Medical background

Key Points

  • Genus plc's stock reached a new 52-week high of GBX 2,555 ($33.97) during trading, closing at GBX 2,506.57 ($33.33) with a trading volume of 847 shares.
  • Analysts have issued a "buy" rating for Genus, with Shore Capital setting a price target of GBX 2,750 ($36.56) and Deutsche Bank raising their target to GBX 2,550 ($33.91).
  • The company operates in animal genetics with a market cap of £1.65 billion and offers products through its three segments: Genus PIC, Genus ABS, and Genus Research and Development.
  • Want stock alerts on Genus? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Shares of Genus plc (LON:GNS - Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 2,555 ($34.36) and last traded at GBX 2,506.57 ($33.71), with a volume of 847 shares trading hands. The stock had previously closed at GBX 2,495 ($33.56).

Analyst Ratings Changes

GNS has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Genus from GBX 2,250 ($30.26) to GBX 2,550 ($34.30) and gave the stock a "buy" rating in a research note on Tuesday, July 15th. Shore Capital reaffirmed a "buy" rating and issued a GBX 2,750 ($36.99) target price on shares of Genus in a research note on Tuesday, July 15th.

View Our Latest Stock Report on GNS

Genus Stock Performance

The firm's 50-day moving average price is GBX 2,194.19 and its 200 day moving average price is GBX 1,974.62. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The company has a market cap of £1.65 billion, a price-to-earnings ratio of 208.89, a PEG ratio of 2.87 and a beta of 0.37.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

See Also

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines